QIAGEN N.V. (QGEN) › Capital ExpendituresQIAGEN N.V. (QGEN) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2008: $39.45M2009: $52.18M2010: $79.67M2011: $86.81M2012: $102.00M2013: $84.47M2014: $86.59M2015: $97.78M2016: $74.54M2017: $90.08M2018: $109.77M2019: $117.95M2020: $132.79M2021: $189.90M2022: $129.22M2023: $149.71M2024: $167.17M2025: $201.05M$201.05M2008Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$201.05M+20.3%2024$167.17M+11.7%2023$149.71M+15.9%2022$129.22M-32.0%2021$189.90M+43.0%2020$132.79M+12.6%2019$117.95M+7.4%2018$109.77M+21.9%2017$90.08M+20.9%2016$74.54M-23.8%2015$97.78M+12.9%2014$86.59M+2.5%2013$84.47M-17.2%2012$102.00M+17.5%2011$86.81M+9.0%2010$79.67M+52.7%2009$52.18M+32.3%2008$39.45M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share